# Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation

> **NCT03821883** · NA · UNKNOWN · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 1120 (estimated)

## Conditions studied

- Atrial Fibrillation
- Stroke
- Bleeding

## Interventions

- **DRUG:** Aspirin Tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03821883
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 1120 (ESTIMATED)
- **Last updated:** 2021-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03821883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03821883, "Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03821883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*